These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1150 related articles for article (PubMed ID: 17949555)

  • 1. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
    Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
    Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications.
    Aksoy Y; Ercan A; Dalmizrak O; Canpinar H; Kartal Durmazlar SP; Bayazit M
    Clin Rheumatol; 2011 Apr; 30(4):515-9. PubMed ID: 20842516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
    Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
    Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?
    Musabak U; Pay S; Erdem H; Simsek I; Pekel A; Dinc A; Sengul A
    Rheumatol Int; 2006 Apr; 26(6):545-50. PubMed ID: 16205927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
    Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
    Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
    Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
    Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
    Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
    Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
    Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
    Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.